Improvements in drug administration, including implantable devices, extended-release formulations, or non-invasive methods (like transdermal patches), may enhance patient satisfaction and broaden market appeal Impacted by recent drug approvals (for diverse applications) and substantial R&D investments from companies (to enhance delivery systems for GLP-1 drugs), the market is projected to witness steady growth in the coming decade
It helps: Increase insulin production to lower blood sugar Slow down digestion, so you feel full faster and longer Suppress appetite and reduce cravings When combined with a healthy diet and exercise, GLP-1 has been shown to promote significant, sustained weight loss and reduce the risk of heart disease, stroke, and other weight-related conditions
Zepbound works in three primary ways: Brain Signaling: It targets areas of the brain that control appetite and hunger, making you feel full faster
However, in the face of chronic, complex illness, this vital defense mechanism can become profoundly overwhelmed and depleted
However, both medications are highly effective, and the best choice depends on individual goals, medical history, and response to treatment
Eli Lilly did not reply to a request for a comment on Chinese approval of the drug, which in the U.S